desipramine has been researched along with Dyskinesia Syndromes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnum, CJ; Bishop, C; Dupre, KB; Eskow, KL | 1 |
| Ikeda, K; Kobayashi, T; Ogai, Y; Ohta, M; Ozaki, M; Takahashi, T; Takamatsu, Y; Yamamoto, H | 1 |
| de Villiers, AS; Douglas, RJ; Kellaway, L; Mintz, M; Tomer, R | 1 |
| Markham, CH | 1 |
| Butz, P; Kaufmann, W; Wiesendanger, M | 1 |
| de Ajuriaguerra, J; Gaillard, JM; Gauthier, G; Guggisberg, M; Tissot, R | 1 |
6 other study(ies) available for desipramine and Dyskinesia Syndromes
| Article | Year |
|---|---|
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Agents; Animals; Benzazepines; Biogenic Monoamines; Brain Chemistry; Chromatography, High Pressure Liquid; Corpus Striatum; Desipramine; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Functional Laterality; Male; Movement Disorders; Oxidopamine; Parkinson Disease; Piperazines; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2008 |
G protein-activated inwardly rectifying K+ channel inhibition and rescue of weaver mouse motor functions by antidepressants.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Cell Death; Desipramine; Fluoxetine; G Protein-Coupled Inwardly-Rectifying Potassium Channels; GTP-Binding Proteins; Mice; Mice, Inbred C3H; Mice, Neurologic Mutants; Movement Disorders; Oocytes; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; RNA, Messenger; Xenopus | 2006 |
Transient contralateral rotation following unilateral substantia nigra lesion reflects susceptibility of the nigrostriatal system to exhaustion by amphetamine.
Topics: Amphetamine; Animals; Corpus Striatum; Desipramine; Dominance, Cerebral; Drug Tolerance; Hydroxydopamines; Male; Motor Activity; Movement Disorders; Oxidopamine; Rats; Rats, Inbred Strains; Rotation; Stress, Physiological; Substantia Nigra | 1986 |
The "on-off" side effect of L-DOPA.
Topics: Age Factors; Amitriptyline; Aromatic Amino Acid Decarboxylase Inhibitors; Athetosis; Carbidopa; Catechol O-Methyltransferase Inhibitors; Chlordiazepoxide; Chorea; Desipramine; Diazepam; Dietary Proteins; Enzyme Inhibitors; Female; Humans; Imipramine; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Physical Exertion; Picolinic Acids; Prochlorperazine; Sex Factors; Stress, Psychological | 1974 |
[Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
Topics: Aged; Carboxy-Lyases; Desipramine; Dihydroxyphenylalanine; Discrimination, Psychological; Drug Synergism; Electromyography; Humans; Infusions, Parenteral; Middle Aged; Movement Disorders; Parasympatholytics; Parkinson Disease; Reaction Time; Thalamus; Trihexyphenidyl | 1969 |
[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
Topics: Adult; Aged; Anemia, Hemolytic; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Cell Count; Carboxy-Lyases; Chorea; Constipation; Desipramine; Dihydroxyphenylalanine; Edema; Female; Humans; Hypotension; Lymphocytosis; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Reticulocytes; Vomiting | 1969 |